The Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) in New York City is pleased to announce that CastleVax, Inc., has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus ...
SAN DIEGO , July 11, 2023 /PRNewswire/ -- The U.S.-Mexico Border Philanthropy Partnership (BPP), the Consulate General of Mexico in San Diego , the California Department of Public Health (CDPH), and Cross Border Xpress (CBX) announce ...
Xulon Press presents a riveting true story to be appreciated by Christians, healthcare workers, and anyone facing illness or struggling with their beliefs and faith. NEWPORT NEWS, Va. , June 15, 2023 /PRNewswire-PRWeb/ -- Authors Dr. ...
The funds will be used to accelerate commercialization of a highly sensitive, fluorescent version of PBM's Status ™ COVID-19/Flu A&B antigen test used in conjunction with C2Sense's Halo ™ diagnostic reader. WATERTOWN, Mass. and ...
WuXi Biologics is the manufacturing partner of InflaRx for Gohibic (vilobelimab), a first-in-class monoclonal anti-C5a antibody. InflaRx received emergency use authorization (EUA) from the FDA for Gohibic (vilobelimab) for the treatment of ...
The shift from pandemic to endemic doesn't alleviate all concerns as nations worldwide continue to manage COVID-19 along with other respiratory viruses and diseases. This includes maintaining and strengthening commitments to in vitro diagnostic ...
Study Reveals Electroluminescent Film-Based Fingerprint Scanners Are One of the Safest Things to Touch in Public COLUMBIA, Mo. , May 9, 2023 /PRNewswire/ -- Researchers at the University of Missouri Laboratory for Infectious ...
CHICAGO, May 02, 2023 (GLOBE NEWSWIRE) -- An international design competition is underway for a Covid memorial monument. The winning design will be awarded $20,000 USD. A distinguished panel of judges will make the selection. The final ...
GERMANTOWN, Md. and GUANGZHOU, China , April 27, 2023 /PRNewswire/ -- RNAimmune, Inc. (the " Company " or " RNAimmune "), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, ...
OEGSTGEEST, The Netherlands , April 27, 2023 /PRNewswire/ -- ISA Pharmaceuticals, B.V., a clinical stage biotech company developing immunotherapies to treat cancers and infectious diseases, is pleased to announce that it will be ...
White blood cell counts or leukocytes could be a crucial indicator of COVID-19 severity in women, impacting treatment strategies, stated new research.
Nearly 70% of patients report lingering symptoms of Long-COVID, highlighting its widespread impact and need for ongoing research and care solutions.
Newly developed vaccine could protect against emerging SARS-CoV-2 variants and related coronaviruses that may jump from animals to humans.
AI reveals hidden care needs in Long COVID patients, helping physicians offer targeted treatments and improve patient outcomes with personalized care strategies.
Human Metapneumovirus (HMPV) is causing respiratory issues in China, with flu-like symptoms, spreading through droplets. Precautionary measures include hygiene and masks.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers